Discovery process and pharmacological characterization of 2-(S)-(4-fluoro-2-methylphenyl)piperazine-1-carboxylic acid [1-(R)-(3,5-bis-trifluoromethylphenyl)ethyl]methylamide (vestipitant) as a potent, selective, and orally active NK1 receptor antagonist.
J Med Chem
; 52(10): 3238-47, 2009 May 28.
Article
en En
| MEDLINE
| ID: mdl-19388677
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Piperazinas
/
Piperidinas
/
Antagonistas del Receptor de Neuroquinina-1
Límite:
Animals
Idioma:
En
Año:
2009
Tipo del documento:
Article